JP5890769B2 - がんの予防及び治療のためのｍｓｉ特異的なフレームシフトペプチド（ｆｓｐ） - Google Patents

がんの予防及び治療のためのｍｓｉ特異的なフレームシフトペプチド（ｆｓｐ） Download PDF

Info

Publication number
JP5890769B2
JP5890769B2 JP2012272828A JP2012272828A JP5890769B2 JP 5890769 B2 JP5890769 B2 JP 5890769B2 JP 2012272828 A JP2012272828 A JP 2012272828A JP 2012272828 A JP2012272828 A JP 2012272828A JP 5890769 B2 JP5890769 B2 JP 5890769B2
Authority
JP
Japan
Prior art keywords
fsp
vaccine
vector
cancer
msi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012272828A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014118361A5 (enExample
JP2014118361A (ja
Inventor
クロール、マティーアス
ロイシェンバッハ、ミリアム
フォン・クネベル−デベリッツ、マグヌス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaet Heidelberg
Original Assignee
Universitaet Heidelberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaet Heidelberg filed Critical Universitaet Heidelberg
Priority to JP2012272828A priority Critical patent/JP5890769B2/ja
Publication of JP2014118361A publication Critical patent/JP2014118361A/ja
Publication of JP2014118361A5 publication Critical patent/JP2014118361A5/ja
Application granted granted Critical
Publication of JP5890769B2 publication Critical patent/JP5890769B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP2012272828A 2012-12-13 2012-12-13 がんの予防及び治療のためのｍｓｉ特異的なフレームシフトペプチド（ｆｓｐ） Active JP5890769B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012272828A JP5890769B2 (ja) 2012-12-13 2012-12-13 がんの予防及び治療のためのｍｓｉ特異的なフレームシフトペプチド（ｆｓｐ）

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012272828A JP5890769B2 (ja) 2012-12-13 2012-12-13 がんの予防及び治療のためのｍｓｉ特異的なフレームシフトペプチド（ｆｓｐ）

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015149569A Division JP2016028025A (ja) 2015-07-29 2015-07-29 がんの予防及び治療のためのｍｓｉ特異的なフレームシフトペプチド（ｆｓｐ）

Publications (3)

Publication Number Publication Date
JP2014118361A JP2014118361A (ja) 2014-06-30
JP2014118361A5 JP2014118361A5 (enExample) 2015-10-15
JP5890769B2 true JP5890769B2 (ja) 2016-03-22

Family

ID=51173521

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012272828A Active JP5890769B2 (ja) 2012-12-13 2012-12-13 がんの予防及び治療のためのｍｓｉ特異的なフレームシフトペプチド（ｆｓｐ）

Country Status (1)

Country Link
JP (1) JP5890769B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200188496A1 (en) * 2017-06-02 2020-06-18 Arizona Board Of Regents On Behalf Of Arizona State University Universal cancer vaccines and methods of making and using same
IL271966B2 (en) * 2017-07-12 2025-01-01 Nouscom Ag A universal vaccine based on shared neoantigens for the prevention and treatment of cancer (MICRO SATELLITE INSTABLE (MSI))

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO315238B1 (no) * 1998-05-08 2003-08-04 Gemvax As Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
US8053552B2 (en) * 2002-04-18 2011-11-08 Mtm Laboratories, Ag Neopeptides and methods useful for detection and treatment of cancer

Also Published As

Publication number Publication date
JP2014118361A (ja) 2014-06-30

Similar Documents

Publication Publication Date Title
US10682402B2 (en) MSI-specific frameshift peptides (FSP) for prevention and treatment of cancer
KR102351555B1 (ko) Hpv 및 관련 질환용 면역 증강 치료 백신
CN1646153B (zh) 抗血管生成的主动免疫疗法
JP4540033B2 (ja) 腫瘍抗原に対する免疫応答を誘発および／または増強する方法
KR101810840B1 (ko) 암의 예방 및 치료용 msi-특이적 프레임쉬프트 펩티드(fsp)
EP2572725B1 (en) MSI-specific frameshift peptides (FSP) for prevention and treatment of cancer
JP2025003964A (ja) 抗癌ワクチンのための共有腫瘍抗原としてのｈｅｒｖ－ｋ由来抗原
JP2016028025A (ja) がんの予防及び治療のためのｍｓｉ特異的なフレームシフトペプチド（ｆｓｐ）
JP5890769B2 (ja) がんの予防及び治療のためのｍｓｉ特異的なフレームシフトペプチド（ｆｓｐ）
CN104837497B (zh) 用于预防和治疗HPV-相关的肿瘤和其它表达p16的肿瘤的p16INK4a衍生肽
AU2016201986B2 (en) MSI-specific Frameshift Peptides (FSP) for Prevention and Treatment of Cancer
CA2799803C (en) Msi-specific frameshift peptides (fsp) for prevention and treatment of cancer
US20150313979A1 (en) P16ink4a derived peptides for prophylaxis and therapy of hpv-associated tumors and other p16ink4a expressing tumors
EP1373505A2 (en) Tri-hybrid melanoma antigen
HK1190757B (en) Methods and compositions for inducing an immune response to egfrviii
JP2009541235A (ja) 核酸ワクチンのアジュバンド作用のためのｐｐｄの使用
HK1190757A (en) Methods and compositions for inducing an immune response to egfrviii
AU2002244196A1 (en) Tri-hybrid melanoma antigen

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140507

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140801

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140806

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141003

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141008

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141105

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150331

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150729

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20150729

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20151005

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20151215

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160125

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160216

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160219

R150 Certificate of patent or registration of utility model

Ref document number: 5890769

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250